ConductScience.org, home

Paper33489762

A deep intronic variant is a common cause of OTC deficiency in individuals with previously negative genetic testing.

Kumar RD and 6 others. Mol Genet Metab Rep, 2021. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. A deep intronic variant is a common cause of OTC deficiency in individuals with previously negative genetic testing. Papers, record 33489762. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33489762

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A deep intronic variant is a common cause of OTC deficiency in individuals with previously negative genetic testing.
PubMed
Journal
Mol Genet Metab Rep
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.64
iCite
Revised in PubMed
2021-04-02
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kumar RDRunjun D
2Burrage LCLindsay C
3Bartos JJan
4Ali SSaima
5Schmitt EEric
6Nagamani SCSSandesh C S
7LeMons CCynthia

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P50HD103555NIH

Source NIH RePORTER

Download CSV of grants

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119783189Contiguous gene deletion syndrome in a female with ornithine transcarbamylase deficiency.Mol Genet Metab2010https://conductscience.org/library/papers/19783189PubMed
219138872High-frequency detection of deletions and variable rearrangements at the ornithine transcarbamylase (OTC) locus by oligonucleotide array CGH.Mol Genet Metab2009https://conductscience.org/library/papers/19138872PubMed
326059767Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update.J Genet Genomics2015https://conductscience.org/library/papers/26059767PubMed
411793483
Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.
Hum Mutat2002https://conductscience.org/library/papers/11793483PubMed
58794176Urea cycle disorders: diagnosis, pathophysiology, and therapy.Adv Pediatr1996https://conductscience.org/library/papers/8794176PubMed
62035531Identification of RNA splicing errors resulting in human ornithine transcarbamylase deficiency.Am J Hum Genet1991https://conductscience.org/library/papers/2035531PubMed
718440262Analysis of mRNA transcripts improves the success rate of molecular genetic testing in OTC deficiency.Mol Genet Metab2008https://conductscience.org/library/papers/18440262PubMed
811793468Mutations and polymorphisms in the human ornithine transcarbamylase gene.Hum Mutat2002https://conductscience.org/library/papers/11793468PubMed
926446336A novel mutation in ornithine transcarbamylase gene causing mild intermittent hyperammonemia.Saudi Med J2015https://conductscience.org/library/papers/26446336PubMed
1023972786The incidence of urea cycle disorders.Mol Genet Metab2013https://conductscience.org/library/papers/23972786PubMed
1130637984Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION.Mol Genet Genomic Med2019https://conductscience.org/library/papers/30637984PubMed
1226582918ClinVar: public archive of interpretations of clinically relevant variants.Nucleic Acids Res2016https://conductscience.org/library/papers/26582918PubMed
1329282796Disease-causing mutations in the promoter and enhancer of the ornithine transcarbamylase gene.Hum Mutat2018https://conductscience.org/library/papers/29282796PubMed
148862622
Prenatal monitoring in a family at high risk for ornithine transcarbamylase (OTC) deficiency: a new mutation of an A-to-C transversion in position +4 of intron 1 of the OTC gene that is likely to abolish enzyme activity.
Am J Med Genet1996https://conductscience.org/library/papers/8862622PubMed
1518204299Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.Kobe J Med Sci2007https://conductscience.org/library/papers/18204299PubMed
1616737834The frequent observation of evidence for nonsense-mediated decay in RNA from patients with carbamyl phosphate synthetase I deficiency.Mol Genet Metab2006https://conductscience.org/library/papers/16737834PubMed
1721120950Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations.Hum Mutat2011https://conductscience.org/library/papers/21120950PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42947220Longitudinal outcomes of non-transplanted ornithine transcarbamylase deficiency in males and females: a multicentre UK natural history cohort.Orphanet J Rare Dis2026https://conductscience.org/library/papers/42947220PubMed
39449289Exploring RNA therapeutics for urea cycle disorders.J Inherit Metab Dis2024https://conductscience.org/library/papers/39449289PubMed
36620386Considerations for prenatal and postpartum management of a female patient with ornithine transcarbamylase deficiency.Mol Genet Metab Rep2022https://conductscience.org/library/papers/36620386PubMed
36561316Intronic variants in inborn errors of metabolism: Beyond the exome.Front Genet2022https://conductscience.org/library/papers/36561316PubMed
36303552Pathogenic variants of ornithine transcarbamylase deficiency: Nation-wide study in Japan and literature review.Front Genet2022https://conductscience.org/library/papers/36303552PubMed
36065636Clinical exome sequencing uncovers a high frequency of Mendelian disorders in infants with stroke: A retrospective analysis.Am J Med Genet A2022https://conductscience.org/library/papers/36065636PubMed
35822098A serendipitous journey to a promoter variant: The c.-106C>A variant and its role in late-onset ornithine transcarbamylase deficiency.JIMD Rep2022https://conductscience.org/library/papers/35822098PubMed
34362010Characterization and Treatment Responsiveness of Genetically Engineered Ornithine Transcarbamylase-Deficient Pig.J Clin Med2021https://conductscience.org/library/papers/34362010PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33489762

GET https://conductscience.org/api/papers/v1/33489762/authors